It seems like everyone is talking about quality these days. As a quality leader first and foremost you’re focused on improving the care of your patients, but somehow, you find yourself dedicating more and more time to meeting regulatory requirements because that’s when you find yourself answering to your C-suite.
You talk to the CFO because your organization got a readmission penalty and the CIO because there are technical issues to sort out and the CCO because they want to confirm you’ve met all the regulatory requirements and did the CEO just ask you about your star rating because it’s affecting your public reputation? It seems like you can only get their ear when they want to discuss something they need.
It’s time for you as a quality leader to take control of these various aspects of regulatory reporting and position yourself as an enterprise-wide strategic asset.
This strategy paper outlines practical advice and tactics to help the c-suite focus on the vision and needs of your quality department.
To successfully elevate your strategic profile, you must expertly manage your revenue-at-risk programs. Here, we focus on the three big revenue-at-risk programs for hospitals and health systems.
Hospital-Acquired Condition Reduction Program (HACRP)
Hospital Readmissions Reduction Program (HRRP)
Hospital Value-Based Purchasing Program (HVBPP)
Download the strategy paper now.
Erin Heilman is the Vice President of Marketing for Medisolv, Inc.